CVE-2026-70670Vulnerability in the Oracle Reports Developer product of Oracle Fusion Middleware (component: Security and Authentication).
Updated under an hour ago ()
Does this affect you?
It affects Oracle Corporation Oracle Reports Developer. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Vulnerability in the Oracle Reports Developer product of Oracle Fusion Middleware (component: Security and Authentication). The supported version that is affected is 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with access to the physical communication segment attached to the hardware where the Oracle Reports Developer executes to compromise Oracle Reports Developer. While the vulnerability is in Oracle Reports Developer, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle Reports Developer. CVSS 3.1 Base Score 9.6 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H).
- CVSS
- 9.6 CRITICAL (v3.1, CNA)CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- CWE-284
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- oracle
- NVD analysis
- Analyzed
- Record last updated
- Aug 25, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Oracle Corporation Oracle Reports Developer oracle:reports_developer (from the name) | 14.1.2.0.0 | CNA record |
oracle reports_developer oracle:reports_developer | 14.1.2.0.0 | NVD |
References
- https://www.oracle.com/security-alerts/cspuaug2026.htmlvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.